An interventional study of No drug or device, only a test. The test is called a PET/CT in Arterial Inflammation, sponsored by University of California, Los Angeles. Completed at 1 site in United States. Open to participants aged 21 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-10-04.
Sponsored by University of California, Los Angeles · Not applicable, Interventional, and Diagnostic
Arterial inflammation will be compared using PET scanning in 3 groups: 1) Non-smokers, 2) Tobacco cigarette smokers, 3) Electronic cigarette users.
Qualified participants will undergo a singe PET/CT to detect arterial inflammation.
20 studies on the registry are indexed under Arteritis; 3 are open to participants now.
This study's enrollment of 30 is below the median of 64 across 12 interventional studies indexed under Arteritis.
Browse Arteritis studies →University of California, Los Angeles is the lead sponsor of 1,170 studies on the registry; 195 are open to participants now.
Of its 95 completed or terminated interventional studies of FDA-regulated products, 70 (74%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Healthy
Exclusion Criteria:
Will undergo PET scan as a "negative control"
Other: No drug or device, only a test. The test is called a PET/CT
Will undergo PET scan as a "positive control"
Other: No drug or device, only a test. The test is called a PET/CT
Will undergo PET scan
Other: No drug or device, only a test. The test is called a PET/CT
A single PET/CT scan will be performed
target-to-background ratio (TBR)
TBR will be detected on the scan
Time frame: intraoperative
The record gives a start of Jul 2015, a primary completion of Feb 2023 and a completion of Feb 2023. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of California, Los Angeles →